United States Capecitabine Market Report & Forecast 2021-2027

United States Capecitabine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Capecitabine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Capecitabine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Capecitabine Overall Market Size
2.1 United States Capecitabine Market Size: 2021 VS 2027
2.2 United States Capecitabine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Capecitabine Sales: 2016-2027
3 Company Landscape
3.1 Top Capecitabine Players in United States Market
3.2 Top United States Capecitabine Companies Ranked by Revenue
3.3 United States Capecitabine Revenue by Companies
3.4 United States Capecitabine Sales by Companies
3.5 United States Capecitabine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Capecitabine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Capecitabine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Capecitabine Players in United States Market
3.8.1 List of Tier 1 Capecitabine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Capecitabine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Capecitabine Market Size Markets, 2021 & 2027
4.1.2 500 mg
4.1.3 150 mg
4.2 By Type - United States Capecitabine Revenue & Forecasts
4.2.1 By Type - United States Capecitabine Revenue, 2016-2021
4.2.2 By Type - United States Capecitabine Revenue, 2022-2027
4.2.3 By Type - United States Capecitabine Revenue Market Share, 2016-2027
4.3 By Type - United States Capecitabine Sales & Forecasts
4.3.1 By Type - United States Capecitabine Sales, 2016-2021
4.3.2 By Type - United States Capecitabine Sales, 2022-2027
4.3.3 By Type - United States Capecitabine Sales Market Share, 2016-2027
4.4 By Type - United States Capecitabine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Capecitabine Market Size, 2021 & 2027
5.1.2 Breast Cancer
5.1.3 Colorectal Cancer
5.1.4 Stomach Cancer
5.2 By Application - United States Capecitabine Revenue & Forecasts
5.2.1 By Application - United States Capecitabine Revenue, 2016-2021
5.2.2 By Application - United States Capecitabine Revenue, 2022-2027
5.2.3 By Application - United States Capecitabine Revenue Market Share, 2016-2027
5.3 By Application - United States Capecitabine Sales & Forecasts
5.3.1 By Application - United States Capecitabine Sales, 2016-2021
5.3.2 By Application - United States Capecitabine Sales, 2022-2027
5.3.3 By Application - United States Capecitabine Sales Market Share, 2016-2027
5.4 By Application - United States Capecitabine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Overview
6.1.3 Roche Capecitabine Sales and Revenue in United States Market (2016-2021)
6.1.4 Roche Capecitabine Product Description
6.1.5 Roche Recent Developments
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Overview
6.2.3 Teva Capecitabine Sales and Revenue in United States Market (2016-2021)
6.2.4 Teva Capecitabine Product Description
6.2.5 Teva Recent Developments
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Overview
6.3.3 Mylan Capecitabine Sales and Revenue in United States Market (2016-2021)
6.3.4 Mylan Capecitabine Product Description
6.3.5 Mylan Recent Developments
6.4 Hikma
6.4.1 Hikma Corporation Information
6.4.2 Hikma Overview
6.4.3 Hikma Capecitabine Sales and Revenue in United States Market (2016-2021)
6.4.4 Hikma Capecitabine Product Description
6.4.5 Hikma Recent Developments
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Corporation Information
6.5.2 Hengrui Medicine Overview
6.5.3 Hengrui Medicine Capecitabine Sales and Revenue in United States Market (2016-2021)
6.5.4 Hengrui Medicine Capecitabine Product Description
6.5.5 Hengrui Medicine Recent Developments
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Overview
6.6.3 Cipla Capecitabine Sales and Revenue in United States Market (2016-2021)
6.6.4 Cipla Capecitabine Product Description
6.6.5 Cipla Recent Developments
6.7 Reliance Group
6.7.1 Reliance Group Corporation Information
6.7.2 Reliance Group Overview
6.7.3 Reliance Group Capecitabine Sales and Revenue in United States Market (2016-2021)
6.7.4 Reliance Group Capecitabine Product Description
6.7.5 Reliance Group Recent Developments
6.8 Hetero
6.8.1 Hetero Corporation Information
6.8.2 Hetero Overview
6.8.3 Hetero Capecitabine Sales and Revenue in United States Market (2016-2021)
6.8.4 Hetero Capecitabine Product Description
6.8.5 Hetero Recent Developments
7 United States Capecitabine Production Capacity, Analysis
7.1 United States Capecitabine Production Capacity, 2016-2027
7.2 Capecitabine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Capecitabine Supply Chain Analysis
9.1 Capecitabine Industry Value Chain
9.2 Capecitabine Upstream Market
9.3 Capecitabine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Capecitabine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Capecitabine in United States Market
Table 2. Top Capecitabine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Capecitabine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Capecitabine Revenue Share by Companies, 2016-2021
Table 5. United States Capecitabine Sales by Companies, (Kg), 2016-2021
Table 6. United States Capecitabine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Capecitabine Price (2016-2021) & (USD/g)
Table 8. Manufacturers Capecitabine Product Type
Table 9. List of Tier 1 Capecitabine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Capecitabine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of 500 mg
Table 12. Major Manufacturers of 150 mg
Table 13. By Type - United States Capecitabine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Capecitabine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Capecitabine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Capecitabine Sales (Kg), 2016-2021
Table 17. By Type - United States Capecitabine Sales (Kg), 2022-2027
Table 18. By Application - United States Capecitabine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Capecitabine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Capecitabine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Capecitabine Sales (Kg), 2016-2021
Table 22. By Application - United States Capecitabine Sales (Kg), 2022-2027
Table 23. Roche Corporation Information
Table 24. Roche Description and Major Businesses
Table 25. Roche Capecitabine Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/g) (2016-2021)
Table 26. Roche Capecitabine Product
Table 27. Roche Recent Developments
Table 28. Teva Corporation Information
Table 29. Teva Description and Major Businesses
Table 30. Teva Capecitabine Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/g) (2016-2021)
Table 31. Teva Capecitabine Product
Table 32. Teva Recent Developments
Table 33. Mylan Corporation Information
Table 34. Mylan Description and Major Businesses
Table 35. Mylan Capecitabine Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/g) (2016-2021)
Table 36. Mylan Capecitabine Product
Table 37. Mylan Recent Developments
Table 38. Hikma Corporation Information
Table 39. Hikma Description and Major Businesses
Table 40. Hikma Capecitabine Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/g) (2016-2021)
Table 41. Hikma Capecitabine Product
Table 42. Hikma Recent Developments
Table 43. Hengrui Medicine Corporation Information
Table 44. Hengrui Medicine Description and Major Businesses
Table 45. Hengrui Medicine Capecitabine Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/g) (2016-2021)
Table 46. Hengrui Medicine Capecitabine Product
Table 47. Hengrui Medicine Recent Developments
Table 48. Cipla Corporation Information
Table 49. Cipla Description and Major Businesses
Table 50. Cipla Capecitabine Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/g) (2016-2021)
Table 51. Cipla Capecitabine Product
Table 52. Cipla Recent Developments
Table 53. Reliance Group Corporation Information
Table 54. Reliance Group Description and Major Businesses
Table 55. Reliance Group Capecitabine Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/g) (2016-2021)
Table 56. Reliance Group Capecitabine Product
Table 57. Reliance Group Recent Developments
Table 58. Hetero Corporation Information
Table 59. Hetero Description and Major Businesses
Table 60. Hetero Capecitabine Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/g) (2016-2021)
Table 61. Hetero Capecitabine Product
Table 62. Hetero Recent Developments
Table 63. Capecitabine Production Capacity (Kg) of Key Manufacturers in United States Market, 2019-2021 (Kg)
Table 64. United States Capecitabine Capacity Market Share of Key Manufacturers, 2019-2021
Table 65. Capecitabine Market Opportunities & Trends in United States Market
Table 66. Capecitabine Market Drivers in United States Market
Table 67. Capecitabine Market Restraints in United States Market
Table 68. Capecitabine Raw Materials
Table 69. Capecitabine Raw Materials Suppliers in United States Market
Table 70. Typical Capecitabine Downstream
Table 71. Capecitabine Downstream Clients in United States Market
Table 72. Capecitabine Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Capecitabine Product Picture
Figure 2. Capecitabine Segment by Type
Figure 3. Capecitabine Segment by Application
Figure 4. United States Capecitabine Market Overview: 2020
Figure 5. United States Capecitabine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Capecitabine Revenue, 2016-2027 (US$, Mn)
Figure 7. Capecitabine Sales in United States Market: 2016-2027 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Capecitabine Revenue in 2020
Figure 9. 500 mg Product Picture
Figure 10. 150 mg Product Picture
Figure 11. By Type - United States Capecitabine Sales Market Share, 2016-2027
Figure 12. By Type - United States Capecitabine Revenue Market Share, 2016-2027
Figure 13. By Type - United States Capecitabine Price (USD/g), 2016-2027
Figure 14. Breast Cancer
Figure 15. Colorectal Cancer
Figure 16. Stomach Cancer
Figure 17. By Application - United States Capecitabine Sales Market Share, 2016-2027
Figure 18. By Application - United States Capecitabine Revenue Market Share, 2016-2027
Figure 19. By Application - United States Capecitabine Price (USD/g), 2016-2027
Figure 20. Roche Capecitabine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Teva Capecitabine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Mylan Capecitabine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Hikma Capecitabine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Hengrui Medicine Capecitabine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Cipla Capecitabine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Reliance Group Capecitabine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Hetero Capecitabine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. United States Capecitabine Production Capacity (Kg), 2016-2027
Figure 29. Capecitabine Industry Value Chain
Figure 30. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs